Skip to main content
Back to Deerfield

Deerfield's Oncology Portfolio

Browse 6 Oncology companies funded by Deerfield. See funding amounts, founder contacts, and investment details.

Oncology Companies
6
Total Funding in Oncology
$719.4M

Oncology Portfolio Companies (6)

Export
BiotechnologyGeneticsHealth CareHealth DiagnosticsMedical DeviceOncology

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Ann Arbor, United States
July 2021
$90.0M
Series C

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncology

Platform therapeutics company advancing novel treatments for Oncology, Neurodegenerative Disorders, and Rare Diseases

New York, United States
May 2022
$400K
Pre-Seed

Founder Contacts

41,000+ verified contacts

BiotechnologyLife ScienceOncologyTherapeutics

Werewolf Therapeutics operates as an oncology biotherapeutics company.

Cambridge, United States
May 2022
$50.0M
Post-IPO Secondary

Founder Contacts

41,000+ verified contacts

BiotechnologyMedicalOncologyTherapeutics

Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.

Cambridge, United States
April 2022
$20.0M
Post-IPO Debt

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Cambridge, United States
February 2026
$150.0M
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

BiopharmaBiotechnologyHealth CareOncology

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

Waltham, United States
June 2016
$409.0M
Post Ipo Equity

Founder Contacts

41,000+ verified contacts

Explore Deerfield's Full Portfolio

View all companies funded by Deerfield across every industry and funding stage.

View Full Deerfield Portfolio